196 related articles for article (PubMed ID: 20870476)
1. Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution.
Itinteang T; Brasch HD; Tan ST; Day DJ
J Plast Reconstr Aesthet Surg; 2011 Jun; 64(6):759-65. PubMed ID: 20870476
[TBL] [Abstract][Full Text] [Related]
2. Low-dose propranolol for infantile haemangioma.
Tan ST; Itinteang T; Leadbitter P
J Plast Reconstr Aesthet Surg; 2011 Mar; 64(3):292-9. PubMed ID: 20615772
[TBL] [Abstract][Full Text] [Related]
3. β-blocker therapy for infantile hemangioma.
Koh SP; Leadbitter P; Smithers F; Tan ST
Expert Rev Clin Pharmacol; 2020 Aug; 13(8):899-915. PubMed ID: 32662682
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of renin, angiotensin-converting enzyme and angiotensin II in patients treated by surgical excision, propranolol and captopril for problematic proliferating infantile haemangioma.
Sulzberger L; Baillie R; Itinteang T; de Jong S; Marsh R; Leadbitter P; Tan ST
J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):381-6. PubMed ID: 26612192
[TBL] [Abstract][Full Text] [Related]
5. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
Holmes WJ; Mishra A; Gorst C; Liew SH
J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
[TBL] [Abstract][Full Text] [Related]
6. [Medical treatment of children with infantile haemangiomas].
Velure HK; Hartling UB; Schuster A; Bygum A
Ugeskr Laeger; 2017 Feb; 179(8):. PubMed ID: 28397661
[TBL] [Abstract][Full Text] [Related]
7. Haemangioma and propranolol.
Engberg Damsgaard T; Vandborg Bjerre J
J Plast Surg Hand Surg; 2014 Feb; 48(1):86-8. PubMed ID: 23837510
[TBL] [Abstract][Full Text] [Related]
8. Facial segmental haemangioma with PHACE Syndrome successfully treated with oral propranolol.
Lim TH; Yap E; Norhatizah BS
Med J Malaysia; 2019 Oct; 74(5):447-449. PubMed ID: 31649228
[TBL] [Abstract][Full Text] [Related]
9. Low-dose propranolol regimen for infantile haemangioma.
Tan CE; Itinteang T; Leadbitter P; Marsh R; Tan ST
J Paediatr Child Health; 2015 Apr; 51(4):419-24. PubMed ID: 25187156
[TBL] [Abstract][Full Text] [Related]
10. Use of propranolol in infantile haemangioma among Chinese children.
Chik KK; Luk CK; Chan HB; Tan HY
Hong Kong Med J; 2010 Oct; 16(5):341-6. PubMed ID: 20889997
[TBL] [Abstract][Full Text] [Related]
11. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function.
Tan ST; Itinteang T; Leadbitter P
Pediatrics; 2011 Mar; 127(3):e772-6. PubMed ID: 21357335
[TBL] [Abstract][Full Text] [Related]
12. The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action.
Ji Y; Chen S; Xu C; Li L; Xiang B
Br J Dermatol; 2015 Jan; 172(1):24-32. PubMed ID: 25196392
[TBL] [Abstract][Full Text] [Related]
13. Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.
Phillips JD; Zhang H; Wei T; Richter GT
JAMA Facial Plast Surg; 2017 Mar; 19(2):102-107. PubMed ID: 27737446
[TBL] [Abstract][Full Text] [Related]
14. Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.
Greenberger S; Bischoff J
Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a006460. PubMed ID: 22229118
[TBL] [Abstract][Full Text] [Related]
15. Treatment of infantile hemangiomas with propranolol: clinical guidelines.
Szychta P; Stewart K; Anderson W
Plast Reconstr Surg; 2014 Apr; 133(4):852-862. PubMed ID: 24352207
[TBL] [Abstract][Full Text] [Related]
16. Infantile hemangioma associated with PHACES syndrome showing a dramatic response to oral propranolol.
Singh BA; Harsha YS; Reddy BS
Indian J Dermatol Venereol Leprol; 2015; 81(5):549. PubMed ID: 26087086
[No Abstract] [Full Text] [Related]
17. Capillary haemangioma successfully treated with oral beta-blocker in Dar es Salaam, Tanzania: a case report.
Cloke A; Lim LT; Blaikie A
Semin Ophthalmol; 2013 Jan; 28(1):32-3. PubMed ID: 23305438
[TBL] [Abstract][Full Text] [Related]
18. Propranolol in the management of periorbital infantile haemangioma.
Cheng JF; Gole GA; Sullivan TJ
Clin Exp Ophthalmol; 2010 Aug; 38(6):547-53. PubMed ID: 20553300
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of infantile haemangioma.
Greenberger S; Bischoff J
Br J Dermatol; 2013 Jul; 169(1):12-9. PubMed ID: 23668474
[TBL] [Abstract][Full Text] [Related]
20. Primitive mesodermal cells with a neural crest stem cell phenotype predominate proliferating infantile haemangioma.
Itinteang T; Tan ST; Brasch H; Day DJ
J Clin Pathol; 2010 Sep; 63(9):771-6. PubMed ID: 20696686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
